Genscript Biotech Corp (OTCPK:GNNSF)
$ 1.26 0 (0%) Market Cap: 2.94 Bil Enterprise Value: 1.51 Bil PE Ratio: 0 PB Ratio: 2.17 GF Score: 66/100

Q2 2023 Genscript Biotech Corp Earnings Call Transcript

Aug 20, 2023 / 11:30PM GMT
Operator

Hello, and welcome to the GenScript Biotech Interim 2023 Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

It is now my pleasure to introduce IR Director, Pengfei.

Duan Pengfei

Thank you, Andrew. Hi, everyone. Welcome to GenScript 2023 Interim Results Conference Call. I'm Pengfei Duan, Investor Relations Director at GenScript.

Joining me on the call today are Mr. Robin Meng, Chair of the Board; Ms. Sherry Shao, Rotating CEO; Dr. Patrick Liu, Off-duty Rotating CEO; and Mr. Shiniu Wei, CFO of GenScript. We also have key leaders from subsidiaries and business units joining us.

Before we begin, I would like to remind everyone that on today's call we will be making statements about future expectations, plans and prospects as well as any other statements regarding matters that are not historical facts, which may constitute forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements. Because of various important risk factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot